Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.
  • Posted by Pei Li Teh
  • May 30, 2018
  • Events

Eyeforpharma Real World Evidence Conference Round up 2018

Earlier this month, APAC Director Pei Li Teh attended Asia’s 11th Eyeforpharma conference in Tokyo, Japan with a focus on Real World Evidence (RWE)

This year has seen a turning point for Japan's pharma industry, as the government and the industry encourage a rapid move towards increased use of RWE from April 2018. Real World Data (RWD) sources provide an unprecedented opportunity for companies to find, demonstrate and communicate their real value to patients, healthcare and society. The conference included topics addressing commercial and medical needs, allowing both communities to come together for the first time encouraging collaboration across functions.

read more »

  • Posted by Pei Li Teh
  • April 19, 2018
  • Events

Eyeforpharma – Real World Evidence 2018

Eyeforpharma – Real World Evidence 2018

16-17 May in Tokyo, Japan

Research Partnership is delighted to be attending the Eyeforpharma Real World Evidence (RWE) conference in Tokyo, Japan 16-17 May. RWE is currently a very hot topic for the Japanese pharma industry, with an increased push to place RWE as a strategic imperative for pharma.

read more »

  • Posted by Callum McCulloch
  • October 26, 2017
  • Articles

Innovation, sustainability and prosperity: Japan’s healthcare vision for the future

Innovation, sustainability and prosperity: Japan’s healthcare vision for the future

By Callum McCulloch and Marc Yates

In 2015, the Japanese government appointed an advisory panel of young experts to lay out its vision of healthcare in the country for 2035. This vision is a healthcare system that delivers unrivalled health outcomes, provides secure and responsive care for all in society, is sustainable, and contributes to prosperity in the nation and around the world. 
Yet, how achievable is this ideal, and how does the government plan to realize its vision? What is clear is that it will require a paradigm shift – a move from quantity to quality of care and from inputs to value, on care rather than cure, on autonomy over regulation, on national integration rather than fragmentation. 

read more »

North Asia infographic

North Asia infographic

North Asia's largest markets; China, Hong Kong, Japan, South Korea and Taiwan, are home to more than 1.6 billion people and is a key global growth region. With pharmaceutical sales of more than $215bn, it is an attractive region for pharma, however one in which each market differs in terms of opportunities - and challenges.
Click here to view our latest infographic, which provides an overview of the five most-commonly researched, largest pharma markets in North Asia.
Find out more about our experience in emerging markets »
Sign up to receive Rapport Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research. Sign up here » 
 

read more »